Trials / Completed
CompletedNCT00237640
Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- University of Oklahoma · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effects of cinnamon on serum glucose and lipid levels in people with non-insulin dependent type 2 diabetes mellitus.
Detailed description
Forty people with non-insulin dependent type 2 diabetes mellitus will be randomized to receive either cinnamon or placebo for three months. The dose of cinnamon will be one gram daily. Fasting serum glucose, triglyceride, total cholesterol, LDL, HDL, and insulin levels will be measured at baseline and at 1, 2, and 3 months. HbA1c levels will be measured at baseline and at 3 months. Patients will be monitored for compliance, adverse effects, and dietary changes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cinnamon or placebo 500 mg capsule twice daily | Cinnamon 500 mg capsule twice daily or placebo capsule twice daily |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2007-07-01
- Completion
- 2007-07-01
- First posted
- 2005-10-12
- Last updated
- 2008-09-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00237640. Inclusion in this directory is not an endorsement.